Adamis Pharmaceuticals Corp - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ADMP Nasdaq 2834 http://www.adamispharmaceuticals.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Adamis Pharmaceuticals Corp

East Bay Parkinson's drug maker to be swallowed up in potential $450M deal - Oct 11th, 2021 9:44 pm
Adamis Announces Appointment of Meera Desai, Ph.D., to Board of Directors - Oct 4th, 2021 11:30 am
Adamis (ADMP) Begins Dosing in COVID Oral Antiviral Study - Sep 3rd, 2021 4:12 pm
Adamis Stock Jumps As Its Oral COVID-19 Drug Trial Starts Dosing - Sep 2nd, 2021 2:56 pm
Adamis Pharmaceuticals Doses First Patients in Phase 2/3 Clinical Trial for Tempol in the Treatment of COVID-19 - Sep 2nd, 2021 11:30 am
Adamis Announces Appointment of David C. Benedicto as Chief Financial Officer and Other Events - Aug 24th, 2021 8:05 pm
Immunology Journal Publishes Data For Adamis' COVID-19 Candidate - Aug 24th, 2021 5:14 pm
Adamis Pharmaceuticals Announces a Publication with the Human Immune Monitoring Center at Stanford Demonstrating Tempol Significantly Inhibited Multiple Cytokines from COVID-19 Patient’s Cells - Aug 24th, 2021 11:30 am
Adamis Highlights National Institutes of Health (NIH) Article Entitled, “Tempol: A Potential Home Treatment for COVID-19” - Aug 19th, 2021 11:30 am
Adamis Announces Agreement to Sell Portion of US Compounding Business - Aug 4th, 2021 8:05 pm
Adamis Announces Results of 2021 Annual Meeting of Stockholders - Jul 19th, 2021 8:05 pm
Adamis Urges Stockholders to Vote to Reelect the Company’s Board of Directors at Upcoming Annual Meeting on Friday, July 16th - Jul 13th, 2021 12:00 pm
Adamis Sends Letter to Stockholders to Address Jerald A. Hammann’s Costly, Distracting and Misguided Campaign - Jul 1st, 2021 12:00 pm
Adamis Sends Letter to Stockholders Regarding Its Strategic Focus on Tempol as a Potentially Potent Treatment for COVID-19 - Jun 28th, 2021 11:00 am
Are Options Traders Betting on a Big Move in Adamis Pharmaceuticals (ADMP) Stock? - Jun 18th, 2021 12:32 pm
Adamis Files Definitive Proxy Statement and Sends Letter to Stockholders - Jun 14th, 2021 1:00 pm
Is Adamis Pharmaceuticals Corporation (ADMP) Going to Burn These Hedge Funds? - Jun 13th, 2021 6:11 pm
Adamis Provides Update on Clinical Trial Start-Up Progress for Tempol in the Treatment of COVID-19 - Jun 11th, 2021 11:30 am
Adamis Provides Update on ZIMHI™ - Jun 9th, 2021 11:30 am
Adamis Pharma Stock Jumps as NIH Sees Promise in Tempol for COVID-19 - Jun 7th, 2021 1:51 pm